K Chalkidou

Dados Biográficos

ID1742933
NOMEK Chalkidou
PRENOMESK
SOBRENOMEChalkidou
ASSINATURACHALKIDOU K
AFILIAÇÕESImperial College London
ORCID0000-0002-7087-2803
VERIFICADOSim
TOTAL DE OBRAS15
TOTAL DE CITAÇÕES1
TOTAL COMO AUTOR15
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2008
ANO MAIS RECENTE DE PUBLICAÇÃO2025
ÍNDICE H1

  • Gender bias in health financing methods

    Open AccessK Chalkidou, R SullivanARTICLEBMJ Global Health2025

  • No shortcuts to universal health coverage

    Open AccessKumanan Rasanathan, Rudolf Mak et al.ARTICLEBMJ Global Health2025

    Member states of the United Nations have prioritised the achievement of universal health coverage (UHC) by 2030, setting it as a target in the Sustainable Development Goals in 2015 and reaffirming this commitment in subsequent declarations in 2019 and 2023

  • An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare

    Open AccessHugo C Turner, Rachel A Archer et al.ARTICLEFrontiers in Public Health2021

    Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as inconsistent methodologies, may be being used for informing health policy decisions. In addition, there is a lack of open access information and methodological guidance targeted to public health professio…

  • Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries

    Open AccessCassandra Nemzoff, Francis Ruiz et al.ARTICLEBMJ Global Health2021

    INTRODUCTION Traditional health technology assessment (HTA) is a policy-based research process, which aims to improve the efficiency and equity of the healthcare system with the limited financial resources available in healthcare.1 In various countries, traditional HTA has been 'institutionalised'-through the development of dedicated agencies with accepted norms and rules that guide explicit priority setting-over years or decades. These agencies …

  • The journey to UHC

    Open AccessLydia Regan, David Wilson et al.ARTICLEBMJ Global Health2021

    BACKGROUND: Countries are recommended to progressively work towards universal health coverage (UHC), and to make explicit choices regarding the expansion of priority services. However, there is little guidance on how to manage the inclusion of vertical programmes, funded by external partners, in health benefits packages (HBP) in low and middle-income countries (LMICs). OBJECTIVE: We conducted a scoping review to map the inclusion of six vertical …

  • Evaluations of public health interventions produced by health technology assessment agencies

    Open AccessPascale Renée Cyr, Vageesh Jain et al.ARTICLEHealth Policy2021

    OBJECTIVES: Health technology assessments (HTAs) have been suggested as a strategy to bridge the evidence-to-policy gap in public health. It is unclear to what extent HTAs have been prepared to assist decisions to implement public health interventions (PHIs). We aimed to describe the experience of HTA agencies by mapping, classifying, and analyzing the evidence content of HTAs of PHIs. METHODS: We systematically searched databases of 35 HTA agenc…

  • Fairer financing of vaccines in a world living with Covid-19

    Open AccessItamar Megiddo, Justice Nonvignon et al.ARTICLEBMJ Global Health2020

    The COVID-19 pandemic has disrupted routine and campaign-based vaccination, potentially increasing the future vaccine-preventable disease burden and threatening to overwhelm health systems.\n\n- Vaccine-preventable diseases are transboundary problems that require global cooperation to achieve the best outcomes.\n\n- Investments, predominantly by rich countries—in effect transfers to poor countries—are required as part of the financing solution. T…

  • The potential health and revenue effects of a tax on sugar sweetened beverages in Zambia

    Open AccessPeter Hangoma, Maio Bulawayo et al.ARTICLEBMJ Global Health2020

    The global burden of non-communicable diseases (NCDs) has been rising. A key risk factor for NCDs is obesity, which has been partly linked to consumption of sugar sweetened beverages (SSBs). A tax on SSBs is an attractive control measure to curb the rising trend in NCDs, as it has the potential to reduce consumption of SSBs. However, studies on the potential effects of SSB taxes have been concentrated in high-income countries with limited studies…

  • Market-driven, value-based, advance commitment (MVAC)

    Open AccessK Chalkidou, Adrian Towse et al.ARTICLEBMJ Global Health2020

    box:\n- Tuberculosis (TB) is the world’s deadliest infectious disease; without a significant technological breakthrough, current trajectories suggest that the world will not achieve the Convergence 2035 targets for TB until 2074, almost 40 years later than originally projected.\n\n- Research and development investments for TB are dominated by public sources and total only one-third of estimated need, with private investment small and declining.\n…

  • Valuing Protection against Health-Related Financial Risks

    Open AccessJames S Skinner, K Chalkidou et al.ARTICLEJournal of Benefit-Cost Analysis2019Referências: 5

    There is strong interest in both developing and developed countries towards expanding health insurance coverage. How should the benefits, and costs, of expanded coverage be measured? While the value of reducing the financial risks that result from insurance coverage have long been recognized, there has been less attention in how best to measure such benefits. In this paper, we first provide a framework for assessing the financial value from healt…

  • NCD Countdown 2030

    Open AccessJames E Bennett, G A Stevens et al.ARTICLEThe Lancet2018

  • Strengthening health technology assessment systems in the global south

    Open AccessKim MacQuilkan, Peter Baker et al.ARTICLEGlobal Health Action2018

    BACKGROUND: Resource allocation in health is universally challenging, but especially so in resource-constrained contexts in the Global South. Pursuing a strategy of evidence-based decision-making and using tools such as Health Technology Assessment (HTA), can help address issues relating to both affordability and equity when allocating resources. Three BRICS and Global South countries, China, India and South Africa have committed to strengthening…

  • Evidence for overuse of medical services around the world

    Open AccessShannon Brownlee, K Chalkidou et al.ARTICLEThe Lancet2017

  • Sharing the British National Health Service around the world

    Open AccessK Chalkidou, Jeanette VegaARTICLEGlobalization and Health2013

    As the UK reiterates its commitment to protecting and growing its development aid budget amidst an adverse economic environment for the UK and Europe, we discuss the potential to use the country's National Health Service (NHS) model as a vehicle for promoting the country's economic as well as global health diplomacy and development priorities, through a coordinated cross-government plan of action. With the country's Prime Minister serving as a co…

  • Imbalances in funding for clinical and public health research in the UK

    K Chalkidou, A Culyer et al.ARTICLEEvidence & Policy2008Citada por: 1

    National Institute for Health and Clinical Excellence (NICE) recommendations for further research often focus on access, prevention and health promotion, and include population groups traditionally excluded from clinical trials, such as children and minority ethnic groups. NICE and its advisory bodies are starting to work with the National Institute for Health Research to promote research into the clinical and cost-effectiveness of public health …